{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:03:55Z","timestamp":1783109035088,"version":"3.54.6"},"reference-count":23,"publisher":"e-Century Publishing Corporation","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/ehtt9544","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T04:23:58Z","timestamp":1738902238000},"page":"685-692","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of sacral nerve root magnetic stimulation combined with solifenacin in female patients with overactive bladder"],"prefix":"10.62347","volume":"17","author":[{"given":"Yan-Qun","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","unstructured":"Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL and Wein AJ. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327-336.","journal-title":"World J Urol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society","volume":"61","author":"Abrams","year":"2003","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A and Wein A; Standardisation Sub-Committee of the International Continence Society. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003; 61: 37-49.","journal-title":"Urology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/nau.20798","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"29","author":"BT","year":"2010","unstructured":"Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK and Schaer GN; International Urogynecological Association; International Continence Society. An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010; 29: 4-20.","journal-title":"Neurourol Urodyn"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/nau.21072","article-title":"Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China","volume":"30","author":"Wang","year":"2011","unstructured":"Wang Y, Xu K, Hu H, Zhang X, Wang X, Na Y and Kang X. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China. Neurourol Urodyn 2011; 30: 1448-1455.","journal-title":"Neurourol Urodyn"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.18553\/jmcp.2014.20.2.130","article-title":"Economic burden of urgency urinary incontinence in the United States: a systematic review","volume":"20","author":"Coyne","year":"2014","unstructured":"Coyne KS, Wein A, Nicholson S, Kvasz M, Chen CI and Milsom I. Economic burden of urgency urinary incontinence in the United States: a systematic review. J Manag Care Pharm 2014; 20: 130-140.","journal-title":"J Manag Care Pharm"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Malde S, Fry C, Schurch B, Marcelissen T, Averbeck M, Digesu A and Sahai A. What is the exact working mechanism of botulinum toxin A and sacral nerve stimulation in the treatment of overactive bladder\/detrusor overactivity? ICI-RS 2017. Neurourol Urodyn 2018; 37: S108-S116.","DOI":"10.1002\/nau.23552"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/nau.23413","article-title":"Comparative efficacy and tolerability of solifenacin 5 mg\/day versus other oral antimuscarinic agents in overactive bladder: a systematic literature review and network meta-analysis","volume":"37","author":"Nazir","year":"2018","unstructured":"Nazir J, Kelleher C, Aball&#xE9;a S, Maman K, Hakimi Z, Mankowski C and Odeyemi I. Comparative efficacy and tolerability of solifenacin 5 mg\/day versus other oral antimuscarinic agents in overactive bladder: a systematic literature review and network meta-analysis. Neurourol Urodyn 2018; 37: 986-996.","journal-title":"Neurourol Urodyn"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/nau.22544","article-title":"Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder","volume":"34","author":"Siegel","year":"2015","unstructured":"Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennett J, Zylstra S, Berg KC, Kan F and Irwin CP. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn 2015; 34: 224-330.","journal-title":"Neurourol Urodyn"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.eururo.2017.11.002","article-title":"Efficacy and safety of sacral and percutaneous tibial neuromodulation in non-neurogenic lower urinary tract dysfunction and chronic pelvic pain: a systematic review of the literature","volume":"73","author":"Tutolo","year":"2018","unstructured":"Tutolo M, Ammirati E, Heesakkers J, Kessler TM, Peters KM, Rashid T, Sievert KD, Spinelli M, Novara G, Van der Aa F and De Ridder D. Efficacy and safety of sacral and percutaneous tibial neuromodulation in non-neurogenic lower urinary tract dysfunction and chronic pelvic pain: a systematic review of the literature. Eur Urol 2018; 73: 406-418.","journal-title":"Eur Urol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1373375","DOI":"10.3389\/fnins.2024.1373375","article-title":"Efficacy and safety of pelvic floor magnetic stimulation combined with mirabegron in female patients with refractory overactive bladder: a prospective study","volume":"18","author":"Liang","year":"2024","unstructured":"Liang P, Tang QL, Lin T, Tang ZK, Liu FD, Zhou XZ and Tao RZ. Efficacy and safety of pelvic floor magnetic stimulation combined with mirabegron in female patients with refractory overactive bladder: a prospective study. Front Neurosci 2024; 18: 1373375.","journal-title":"Front Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/JU.0000000000000309","article-title":"Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment 2019","volume":"202","author":"Lightner","year":"2019","unstructured":"Lightner DJ, Gomelsky A, Souter L and Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment 2019. J Urol 2019; 202: 558-563.","journal-title":"J Urol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.aju.2013.07.006","article-title":"Overactive bladder syndrome: current pathophysiological concepts and therapeutic approaches","volume":"11","author":"Osman","year":"2013","unstructured":"Osman NI and Chapple CR. Overactive bladder syndrome: current pathophysiological concepts and therapeutic approaches. Arab J Urol 2013; 11: 313-8.","journal-title":"Arab J Urol"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Corcos J, Przydacz M, Campeau L, Gray G, Hickling D, Honeine C, Radomski SB, Stothers L, Wagg A and Lond F. CUA guideline on adult overactive bladder. Can Urol Assoc J 2017; 11: E142-E173.","DOI":"10.5489\/cuaj.4586"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Shalom DF, Pillalamarri N, Xue X, Kohn N, Lind LR, Winkler HA and Metz CN. Sacral nerve stimulation reduces elevated urinary nerve growth factor levels in women with symptomatic detrusor overactivity. Am J Obstet Gynecol 2014; 211: e1-5.","DOI":"10.1016\/j.ajog.2014.07.007"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1438721","DOI":"10.1080\/20016689.2018.1438721","article-title":"Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK","volume":"6","author":"Hakimi","year":"2018","unstructured":"Hakimi Z, Kelleher C, Aball&#xE9;a S, Maman K, Nazir J, Mankowski C and Odeyemi I. Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK. J Mark Access Health Policy 2018; 6: 1438721.","journal-title":"J Mark Access Health Policy"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/iju.13174","article-title":"Long-term prospective study of the persistence of solifenacin succinate in previously untreated Japanese female patients with overactive bladder","volume":"23","author":"Tanaka","year":"2016","unstructured":"Tanaka Y, Tanuma Y and Masumori N. Long-term prospective study of the persistence of solifenacin succinate in previously untreated Japanese female patients with overactive bladder. Int J Urol 2016; 23: 866-872.","journal-title":"Int J Urol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1152\/physrev.00030.2012","article-title":"Urothelial signaling","volume":"93","author":"Birder","year":"2013","unstructured":"Birder L and Andersson KE. Urothelial signaling. Physiol Rev 2013; 93: 653-80.","journal-title":"Physiol Rev"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000477170","article-title":"Association between metabolic syndrome and serum nerve growth factor levels in women with overactive bladder","volume":"83","author":"Dagdeviren","year":"2018","unstructured":"Dagdeviren H and Cengiz H. Association between metabolic syndrome and serum nerve growth factor levels in women with overactive bladder. Gynecol Obstet Invest 2018; 83: 140-144.","journal-title":"Gynecol Obstet Invest"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/S0140-6736(86)91243-2","article-title":"Clinical evaluation of conduction time measurements in central motor pathways using magnetic stimulation of human brain","volume":"1","author":"Barker","year":"1986","unstructured":"Barker AT, Freeston IL, Jabinous R and Jarratt JA. Clinical evaluation of conduction time measurements in central motor pathways using magnetic stimulation of human brain. Lancet 1986; 1: 1325-6.","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/285227a0","article-title":"Stimulation of the cerebral cortex in the intact human subject","volume":"285","author":"Merton","year":"1980","unstructured":"Merton PA and Morton HB. Stimulation of the cerebral cortex in the intact human subject. Nature 1980; 285: 227.","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/(SICI)1520-6777(1999)18:5<505::AID-NAU13>3.0.CO;2-8","article-title":"Induction of urethral closure and inhibition of bladder contraction by continuous magnetic stimulation","volume":"18","author":"Yamanishi","year":"1999","unstructured":"Yamanishi T, Yasuda K, Sakakibara R, Suda S, Ishikawa N, Hattori T and Hosaka H. Induction of urethral closure and inhibition of bladder contraction by continuous magnetic stimulation. Neurourol Urodyn 1999; 18: 505-510.","journal-title":"Neurourol Urodyn"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Bycroft JA, Craggs MD, Sheriff M, Knight S and Shah PJ. Does magnetic stimulation of sacral nerve roots cause contraction or suppression of the bladder? Neurourol Urodyn 2004; 23: 241-245.","DOI":"10.1002\/nau.20009"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s12325-019-01205-z","article-title":"New technologies and applications in sacral neuromodulation: an update","volume":"37","author":"De Wachter","year":"2020","unstructured":"De Wachter S, Knowles CH, Elterman DS, Kennelly MJ, Lehur PA, Matzel KE, Engelberg S and Van Kerrebroeck PEV. New technologies and applications in sacral neuromodulation: an update. Adv Ther 2020; 37: 637-643.","journal-title":"Adv Ther"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/1\/ajtr0160383.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:50:24Z","timestamp":1766022624000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/1\/ajtr0160383.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/ehtt9544","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}